To determine the mechanism by which acute myelogenous leukemia (AML) cells suppress normal marrow granulopoiesis, diffusion chambers containing Wistar/Furth (W/Fu) rat marrow cells, peritoneal exudate (PE) macrophages or W/Fu AML clone-3 cells were implanted intraperitoneally into syngeneic irradiated rats. Growth of each population over 21 days in single or double diffusion chambers (in which cell populations were separated by a Nucleopore® filter) was compared to that of mixed populations. Double diffusion chamber culture of homologous or heterologous combinations had no detectable effect on growth kinetics of any of the three cell populations compared to single chambers. In contrast, normal granulocyte proliferation was significantly depressed by single-chamber co-cultivation with one tenth the number of PE macrophages or AML cells. Mixing PE macrophages with AML cells produced no preferential population suppression. AML cell differentiation was not detected under any set of conditions. These studies demonstrate that physical contact with proliferating normal macrophages as well as AML cells will suppress granulopoiesis in diffusion chambers.

Keywords:
Acute myelogenous leukemia, Rat leukemia, Marrow suppression
This content is only available via PDF.
© 1979 S. Karger AG, Basel
1979
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.